317 related articles for article (PubMed ID: 35798798)
21. Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
Lin SY; Xia W; Kim AK; Chen D; Schleyer S; Choi L; Wang Z; Hamilton JP; Luu H; Hann HW; Chang TT; Hu CT; Woodard A; Gade TP; Su YH
Sci Rep; 2023 Dec; 13(1):21585. PubMed ID: 38062093
[TBL] [Abstract][Full Text] [Related]
22. Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy.
Qu C; Wang Y; Wang P; Chen K; Wang M; Zeng H; Lu J; Song Q; Diplas BH; Tan D; Fan C; Guo Q; Zhu Z; Yin H; Jiang L; Chen X; Zhao H; He H; Wang Y; Li G; Bi X; Zhao X; Chen T; Tang H; Lv C; Wang D; Chen W; Zhou J; Zhao H; Cai J; Wang X; Wang S; Yan H; Zeng YX; Cavenee WK; Jiao Y
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6308-6312. PubMed ID: 30858324
[TBL] [Abstract][Full Text] [Related]
23. Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma.
Phan TH; Chi Nguyen VT; Thi Pham TT; Nguyen VC; Ho TD; Quynh Pham TM; Tran TH; Nguyen TD; Khang Le ND; Nguyen TH; Duong ML; Bach HT; Kim VV; Pham TA; Nguyen BT; Vo Nguyen TN; Nguyen TD; Bieu Phu DT; Huu Phan BH; Nguyen DS; Truong DK; Do TT; Giang H; Nguyen HN; Phan MD; Tran LS
Future Oncol; 2022 Dec; 18(39):4399-4413. PubMed ID: 36786635
[TBL] [Abstract][Full Text] [Related]
24. Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review.
Chen VL; Xu D; Wicha MS; Lok AS; Parikh ND
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2879-2902.e9. PubMed ID: 32289533
[TBL] [Abstract][Full Text] [Related]
25. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
Xu RH; Wei W; Krawczyk M; Wang W; Luo H; Flagg K; Yi S; Shi W; Quan Q; Li K; Zheng L; Zhang H; Caughey BA; Zhao Q; Hou J; Zhang R; Xu Y; Cai H; Li G; Hou R; Zhong Z; Lin D; Fu X; Zhu J; Duan Y; Yu M; Ying B; Zhang W; Wang J; Zhang E; Zhang C; Li O; Guo R; Carter H; Zhu JK; Hao X; Zhang K
Nat Mater; 2017 Nov; 16(11):1155-1161. PubMed ID: 29035356
[TBL] [Abstract][Full Text] [Related]
27. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
29. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
Jeepalyam S; Sheel A; Ejaz A; Miller E; Manne A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762533
[TBL] [Abstract][Full Text] [Related]
30. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR.
Wang J; Yang L; Diao Y; Liu J; Li J; Li R; Zheng L; Zhang K; Ma Y; Hao X
J Int Med Res; 2021 Mar; 49(3):300060521992962. PubMed ID: 33750234
[TBL] [Abstract][Full Text] [Related]
31. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
[TBL] [Abstract][Full Text] [Related]
32. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
[TBL] [Abstract][Full Text] [Related]
33. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
34. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of DNA methylation in hepatocellular carcinoma.
Sceusi EL; Loose DS; Wray CJ
HPB (Oxford); 2011 Jun; 13(6):369-76. PubMed ID: 21609368
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy.
Manoochehri M; Borhani N; Gerhäuser C; Assenov Y; Schönung M; Hielscher T; Christensen BC; Lee MK; Gröne HJ; Lipka DB; Brüning T; Brauch H; Ko YD; Hamann U
Int J Cancer; 2023 Mar; 152(5):1025-1035. PubMed ID: 36305646
[TBL] [Abstract][Full Text] [Related]
37. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.
Lehrich BM; Zhang J; Monga SP; Dhanasekaran R
J Hepatol; 2024 Mar; 80(3):515-530. PubMed ID: 38104635
[TBL] [Abstract][Full Text] [Related]
38. A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma.
Shen H; Wu H; Sun F; Qi J; Zhu Q
Bioengineered; 2021 Dec; 12(1):240-251. PubMed ID: 33380233
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
